PDIA5 and central nervous system cancer: PDIA5 was found to be upregulated in gliomas and related to the suppressive tumor microenvironment by recruiting M2 macrophages, indicating that PDIA5 might be a potential prognostic biomarker or therapy target in the clinical treatment of gliomas.